Determine whether you need to follow legal restrictions. Certain products (e.g., medicines, chemicals, and agricultural fertilizers and pesticides) must be approved by a federal agency (such as swissmedic or the Federal Office of Public Health) in order to protect public health, the environment or other important resources before they can be produced or marketed. Patent owners also require approval in order to bring certain products onto the market. This is because a patent does not automatically confer on its owner the right to use an invention. The patent law does not govern whether and under which conditions an invention may be used. For that there is other applicable legislation, such as a federal drug act or gene technology act.
- Overview of the approval procedure, cantonal procedure, and regulated professions (website of the State Secretariat for Economic Affairs SECO).
17.05.2018 | IP news
Swiss Biotech Report 2018: The Swiss biotech industry continues to soar due to “world class patents”
Info event on using strategic patent analyses on 11.4.2018 in Zurich
14.02.2018 | Event
Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?
Séminaire IPI / LES: «développements récents en droit des marques», jeudi le 9 novembre 2017 au Novotel Genève
Patents and pharmaceuticals - Public event at the IPI in collaboration with the European Patent Office